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Bryophytes, taxonomically placed between the algae and the pteridophytes, are divided
into three classes such as Liverworts, Hornworts and Mosses. Indigenous use involves
this small group of plants to treat various diseases. Bryophytes have been investigated
pharmacologically for active biomolecules. Several constituents with therapeutic potential
have been isolated, characterized and investigated for antibacterial, antifungal, antiviral,
antioxidative, antiinﬂamatory and anticancerous efﬁcacy. The present review deals with
the literature covering the anticancerous potential of bryophytes. Apart from the examples
of the compounds and the containing bryophyte genera, the authors have tried to include
the examples of cancer cell lines on which the efﬁcacy have been tested and the mode of
action of certain cytotoxic agents. Crude extracts and isolated compounds from bryo-
phytes were found to possess potent cytotoxic properties. Different types of terpenoids
and bibenzyls have been reported among the most potent cytotoxic compounds. Most of
these compounds were found to induce apoptosis by activating a number of genes and
enzymes. Biochemical markers such as DNA fragmentation, nuclear condensation, pro-
teolysis of poly (ADP-ribose) polymerase, activation of caspases, inhibition of anti-
apoptotic nuclear transcriptional factor-kappaB, activation of p38 mitogen-activated
protein kinase etc. have been found to be associated with apoptotic and necrotic response.
This review summarizes recent scientiﬁc ﬁndings and suggests further investigations to
evaluate the cytotoxic efﬁcacy of bryophytes.1. Introduction
Plants and natural products have been used as a source of
potential anticancer agents[1–8]. Antitumor agents such as
vincristine, vinblastine the epiodophyllotoxin derivatives,
maytansine, bruceantin, thalicarpine, camptothecin, and
lapachol have been reported from higher plants and their
pharmacology have been reported[9]. Members of Algae[10,11],
Lichen[12,13], Fungi[14,15], pteridophytes[16,17], gymnosperms[18,19]
and angiosperms[20,21] have been evaluated for cytotoxic
properties. Traditional anticancerous and antitumourogenic
plant reports have been pharmacologically investigated and in
many cases scientists have found positive correlation between
folklore use and scientiﬁc analyses[22,23].Bryophytes are a small group of plants devoid of true
vascular tissue. Being small and of insigniﬁcant use, bryophytes
have been neglected in scientiﬁc investigations. Chemical
analysis of active constituents and phytopharmacology of
bryophytes came into the ﬁeld only in the last few decades. With
the advent of modern techniques and methods such as gas
chromatography, gas chromatography-mass spectrometry, nu-
clear magnetic resonance, high performance liquid chromatog-
raphy, high performance thin layer chromatography and X-ray
crystallography, it has been possible to isolate and structurally
elucidate bioactive molecules present in bryophytes[24].
Bryophytes serve as a source of biologically active, naturally
occurring material[25–27]. Antifungal[28,29], antibacterial and
antiviral[30–32], anti inﬂammatory[33], and antioxidative[34,35]
potential in liverworts and mosses has been recorded.
The present review deals with the literature covering the
cytotoxicity and related therapeutic potential of bryophytes.
Several bryophytes have been screened for cytotoxic activ-
ity[36,37]. Crude extracts or various bioactive compounds have
been isolated from liverworts and mosses for anticancerouss reserved.
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carcinoma (KB), P-388 murine leukemia tumor, liver
hepatoblastoma (HEP-G2), lung carcinoma (A549), breast
ductal carcinoma (MDA-MB-435), and colon adenocarcinoma
(LOVO) cell lines, glioma A172 cells, T98G, U87 glioma,
osteosarcoma U2OS, leukemia HL-60, K562 and MDR K562/
A02, MCF-7 breast cancer etc. For reversal activity analyses of
multidrug resistance cancer cell lines, adriamycin-resistant
K562/A02 cells, vincristine-resistant KB/VCR lines etc have
been utilized. Cytotoxic efﬁcacy of the bryophytes was reﬂected
in terms of several biochemical markers of apoptosis and ne-
crosis induction such as DNA fragmentation, nuclear conden-
sation, proteolysis of poly (ADP-ribose) polymerase (PARP),
activation of caspases (a family of cysteine aspartic proteases),
inhibition of antiapoptotic nuclear transcriptional factor-kappaB,
activation of p38 (mitogen-activated protein kinase) etc. Most/
some of these genetic and biochemical machinery play a crucial
role in apoptosis induction. Table 1 depicts the cytotoxic com-
pounds isolated from bryophytes with their chemical structures,Table 1
Structures of cytotoxic phytochemicals from bryophytes.
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from the chemical structure database http://www.chemspider.
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2. Cyotoxic compounds from bryophytes
2.1. Liverworts
Liverworts contain a number of bioactive molecules which
have been utilized to classify them chemosystemically[38,39].
Terpenes are naturally occurring hydrocarbons made up of
several combined isoprene units. Bryophytes possess a number
of terpenoid compounds such as mono, sesqui, di and
triterpenoids, ﬂavonoids, sterols and characteristic phenolic
bibenzyls. Bibenzyls or dihydrostelbene are characteristic
phenolic compounds found in liverworts. Apart from its
occasional existence in some higher plants, these are absent in
hornworts and mosses. Bis (bibenzyls) are derived from two
bibenzyl units linked by some ether linkage[24]. The chemicalsentiﬁc names and molecular formulae
tematic name
,20Z)-5-Methoxy-14-oxapentacyclo[20.2.2.210,13.115,19.02,7]nonacosa-
,6,8,11,15(27),16,18,20,23,25,28-dodecaene-16,24-diol
lecular formula: C29H26O4
tematic name
Oxapentacyclo[20.2.2.210,13.115,19.02,7]nonacosa-
4),2,4,6,10,12,15(27),16,18,22,25,28-dodecaene-5,16,24-triol
lecular formula: C28H24O4
tematic name
4-Dioxapentacyclo[20.2.2.210,13.13,7.115,19]triaconta-
4),3(30),4,6,10,12,15(27),16,18,22,25,28-dodecaene-4,12-diol
lecular formula: C28H24O4
tematic name
2-(4-Hydroxyphenyl)ethyl]phenol
lecular formula: C14H14O2
tematic name
Methoxy-2-oxapentacyclo[22.2.2.13,7.010,15.016,21]nonacosa-
6),3(29),4,6,10,12,14,16,18,20,24,27-dodecaene-4,12-diol
lecular formula: C29H26O4
(continued on next page)
Table 1 (continued )
Cytotoxic phytochemicals from hepatics Scientiﬁc names and molecular formulae
Systematic name
2,15-Dioxapentacyclo[22.2.2.13,7.110,14.016,21]triaconta-
1(26),3(30),4,6,10(29),11,13,16,18,20,24,27-dodecaene-4,5,17-triol
Molecular formula: C28H24O5
Systematic name
2,15-Dioxapentacyclo[22.2.2.13,7.110,14.016,21]triaconta-
1(26),3(30),4,6,10(29),11,13,16,18,20,24,27-dodecaene-4,17-diol
Molecular formula: C28H24O4
Systematic name
8-Methoxy-2,15-dioxapentacyclo[22.2.2.13,7.110,14.016,21]triaconta-
1(26),3(30),4,6,10(29),11,13,16,18,20,24,27-dodecaene-4,5,17-triol
Molecular formula: C29H26O6
Systematic name
4-Methoxy-2,15-dioxapentacyclo[20.2.2.216,19.13,7.110,14]triaconta-
1(24),3(30),4,6,10(29),11,13,16,18,22,25,27-dodecaen-17-ol
Molecular formula: C29H26O4
Systematic name
1-Hydroxy-11,16-cycloabieta-8,15(17)-dien-16-one
Molecular formula: C20H28O2
Systematic name
(5b,10a,13x)-11,16-Cycloabieta-8,15(17)-dien-16-one
Molecular formula: C20H28O
Systematic name
(3aS,6E,10E,11aR)-6,10-Dimethyl-3-methylene-3a,4,5,8,9,11a-
hexahydrocyclodeca[b]furan-2(3H)-one
Molecular formula: C15H20O2
Systematic name
(3aR,4S,6E,10E,11aR)-6,10-Dimethyl-3-methylene-2-oxo-
2,3,3a,4,5,8,9,11a-octahydrocyclodeca[b]furan-4-yl acetate
Molecular formula: C17H22O4
Systematic name
1-[(1S,7S,7aS)-7,7a-Dimethyl-2,3,5,6,7,7a-hexahydro-1H-inden-1-yl]-2-
(hydroxymethyl)-2-propen-1-one
Molecular formula: C15H22O2
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Table 1 (continued )
Cytotoxic phytochemicals from hepatics Scientiﬁc names and molecular formulae
Systematic name
(2Z)-2-[(1R,3aS,4R,7aS)-1,3a,4,7a-Tetramethyloctahydro-5H-inden-5-
ylidene]ethyl (2E)-3-(3,4-dihydroxyphenyl)acrylate
Molecular formula: C24H32O4
Cytotoxic phytochemicals from mosses Scientiﬁc names and molecular formulae
Systematic name
(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-Chloro-21-hydroxy-12,20-
dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-
diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10(26),11,13,16,18-pentaen-6-
yl 2-methylpropanoate
Molecular formula: C32H43ClN2O9
Systematic name
11-Chloro-21-hydroxy-12,15,20-trimethoxy-2,5,9,16-tetramethyl-8,23-
dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-
10(26),11,13,16,18-pentaen-6-yl 2-methylpropanoate
Molecular formula: C33H45ClN2O10
Systematic name
11-Chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-
4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-
10(26),11,13,16,18-pentaen-6-yl 2-[isobutyryl(methyl)amino]propanoa te
(non-preferred name)
Molecular formula: C36H50ClN3O10
Systematic name
11-Chloro-21-hydroxy-12,15,20-trimethoxy-2,5,9,16-tetramethyl-8,23-
dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-
10(26),11,13,16,18-pentaen-6-yl 2-[isobutyryl(methyl)amino]prop anoate
(non-preferred name)
Molecular formula: C37H52ClN3O11
Systematic name
5-Methylene-1,3-cyclopentadiene-1-carboxylic acid
Molecular formula: C7H6O2
Systematic name
(7bR,12bS,14cS)-4-Hydroxy-1,3-dimethoxy-7b,12b,13,14c-tetrahydro-
14H-benzo[c]naphtho[2,1,8-mna]xanthen-14-one
Molecular formula: C25H20O5
Systematic name
(7bR,12bS,14S,14cS)-1,3-Dimethoxy-12b,13,14,14c-tetrahydro-7bH-
benzo[c]naphtho[2,1,8-mna]xanthene-4,14-diol
Molecular formula: C25H22O5
Systematic name
(7bR,12bS,14S,14cS)-1,3,14-Trimethoxy-12b,13,14,14c-tetrahydro-7bH-
benzo[c]naphtho[2,1,8-mna]xanthen-4-ol
Molecular formula: C26H24O5
Systematic name
(2E)-1-(6-Hydroxy-2-phenyl-2,3-dihydro-1-benzofuran-4-yl)-3-phenyl-2-
propen-1-one
Molecular formula: C23H18O3
Systematic name
(2Z)-1-(6-Hydroxy-2-phenyl-2,3-dihydro-1-benzofuran-4-yl)-3-phenyl-2-
propen-1-one
Molecular formula: C23H18O3
Systematic name
7-Hydroxy-2-phenyl-5-[(Z)-2-phenylvinyl]-2,3-dihydro-4H-chromen-4-
one
Molecular formula: C23H18O3
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and bitterness associated with the bryophytes. It was noted
that, 80% of the sesqui- and diterpenoids found in liverworts
are the enantiomers of those found in higher groups of plants[26].
2.1.1. Monoterpenes
Many of the Isoprenyl phenyl ethers from Trichocolea had
shown cytotoxic activity. New Zealand liverwort Trichocolea
mollissima was found to contain methyl 4-[(5-oxogeranyl)oxy]-
3-methoxybenzoate as the major cytotoxic agent. Geranyl ethers
were also found in the Japanese Trichocolea tomentella[40].
Three geranyl phenyl ethers based on the cytotoxic
monoterpenoids were synthesized from the Trichocolea from
New Zealand[41]. Hemi- and monoterpene moieties of isoprenyl
phenyl ethers from Trichocolea tomentella have been
biosynthesized[42]. Presence of monoterpenes has been recorded
from the liverwort Conocephalum conicum[43,44]. A
monoterpene ester, 2 alpha, 5 beta-dihydroxybornane-2-
cinnamate from Chinese Conocephalum conicum has been
found to be moderately cytotoxic against human HepG2 cells[45].
Another liverwort, Jungermannia vulcanicola was also recorded
for possessing monoterpenes[46].
2.1.2. Sesquiterpenes
Isolation, determination of structure, synthesis, chemical and
microbiological transformations of natural sesquiterpenoids[47] and
disesquiterpenoids[48] has been reviewed. Bryophytes contain a
number of sesquiterpenoid compounds, some of which have
shown cytotoxicity. An ent-eudesmanolide known as diplophyl-
line was isolated from Diplophyllum albicans and Diplophyllum
taxifolium. Diplophyllin showed signiﬁcant activity against human
epidermoid carcinoma[49]. Sesquiterpenoids costunolide and
tulipinolide, the tumor growth-inhibiters, also known from higher
plants were isolated from the liverworts Conocephalum supra-
decompositum, Frullania monocera, Frullania tamarisci, March-
antia polymorpha (M. polymorpha), Porella japonica and
Wiesnerella denudata[25,50]. Later on Lepidozia vitrea, Plagiochila
semidecurrens and Plagiochila ovalifolia were added to the
list[51–55]. In another study, some compounds isolated from
bryophytes were assayed for anticancer potential[56]. Potential
anticancer activity of sesquiterpenes of Porella cordeana,
Frullania nisquellensis and Chiloscyphus rivularis were found
and these were categorized among the DNA-damaging natural
products[57]. Methyl ethyl ketone extract of the aquatic liverwort
Chiloscyphus rivularis produced a sesquiterpene, 12-
hydroxychiloscyphone, which was selectively bioactive in yeast-
based DNA-damaging assay and cytotoxic to human lung carci-
noma cells[58]. 2,3-Secoaromadendrane-type sesquiterpenoids were
reported from the Japanese liverwort Plagiochila ovalifolia. The
compounds present in the ether extract were plagiochiline-A-15-yl
octanoate, 14-hydroxyplagiochiline-A-15-yl 2E,4E-dodeca-
dienoate and 14-hydroxyplagiochiline-A-15-yl 2E,4E,8Z-tetrade-
catrienoate of which the ﬁrst two were signiﬁcantly cytotoxic
against P-388 murine leukemia tumor cells[59]. A cytotoxin
selectively active against human tumor cell lines was isolated
from the liverwort Bazzania novae-zelandiae. The active
compound was naviculyl caffeate, a sesquiterpene[60]. Another
cytotoxic sesquiterpenoid compound was reported from the
liverwort from New Zealand Schistochila glaucescens
(S. glaucescens). A sesquiterpene lactone glaucescenolide was
found as a cytotoxic agent against P388 leukemia cells[61].Cytotoxic activitiy of herbertane type sesquiterpenoids (−)-alpha-
herbertenol, (−)-herbertenediol, (−)-mastigophorene C, (−)-mast
igophorene D and (−)-Diplophyllolide A from the Tahitian
liverwort Mastigophora diclados against HL-60 and KB cell
lines was reported[62]. A zierane sesquiterpene gamma-lactone,
chandolide from Tahitian liverwort Chandonanthus hirtellus had
shown weak cytotoxic activity against HL-60[63]. Germacrane- and
pinguisane-type sesquiterpenoids from Indonesian and Tahitian
Frullania sp. and JapanesePorella perrottetiana (P. perrottetiana)
were found to be active against human promyelocytic leukemia
(HL-60) and human pharyngeal squamous carcinoma (KB) cell
lines which were determined by the water soluble tetrazolium-8
colorimetric assay[64].
Some other examples of sesquiterpenoid containing liverworts
are Jungermannia infusca[65,66], Mylia taylorii[67], Mylia nuda[68],
Bryopteris ﬁlicina[69], Frullania densiloba[70], Frullania tamarisci
subsp. obscura[71], Ptilidium ciliare[72], Jubula japonica[73],
Dumortiera hirsuta[74,75], Lejeunea aquatica, Lejeunea ﬂava and
Lejeunea japonica[76], Plagiomnium acutum[77], Chiloscyphus
polyanthus[78], Chiloscyphus subporosus[79], Porella swartziana[80],
Porella recurva[81], Porella subobtusa[82], Porella acutifolia subsp
tosana[83,84], Scapania undulata[85], Lepicolea ochroleuca[86],
Gackstroemia sp., Dendromastigophora sp.,[87] Lepidozia
fauriana[88], etc. These liverwort genera possessing sesquiterpen
oid compound could be exploited as a natural source of cytotoxic
compounds.
2.1.3. Diterpenoids
Cytotoxic 8,9-secokaurane diterpenes active against human
tumor cell lines from a New Zealand liverwort, Lepidolaena
taylorii were reported[89]. 8,9-Secokauranes from the same spe-
cies were reported as cytotoxic against human tumor cell lines.
In addition, two 8,9-secokauranes from the New Zealand liver-
wort Lepidolaena palpebrifolia showed cytotoxicity[90]. Some
human tumor cells were found to be inhibited by cytotoxic
effects of a novel ent-labdane type diterpenoid, muscicolone
isolated from the liverwort Frullania muscicola[91]. New ent-
kaurene-type diterpenoids found in the liverwort Jungerman-
nia sp. showed cytotoxicity against a human leukemia cell
linex[92]. Ent-11alpha-hydroxy-16-kauren-15-one from the
liverwort Jungermannia truncata was found to have apoptosis-
inducing properties. Cytotoxicity of the compound against HL-
60 cells may be dependent on caspases activation[93]. It was
noted that, ent-kaurene-type diterpenoids acted in a caspase-
dependent manner in HL-60 cells[94]. Ent-11alpha-hydroxy-16-
kauren-15-one promoted apoptosis by tumor necrosis factor in
human leukemia cells[95]. Novel cytotoxic kaurene- and ent-
kaurene-type diterpenoids from the same plant was recor-
ded[96]. Ent-11alpha-hydroxy-16-kauren-15-one induced
apoptosis could be mediated by p38 mitogen-activated protein
kinase p38 (MAPK)[97]. In another study, new ent-kaurene
diterpenoids jungermannenones A,B,C and D isolated from the
same were reported to be tumor inhibiting through a caspase-
dependent pathway[98]. Cis-Clerodane diterpenoids have been
reported from the wild liverwort Gottschelia schizopleura and
their cytotoxic activity have been tested against liver hepato-
blastoma (HEP-G2), lung carcinoma (A549), breast ductal car-
cinoma (MDA-MB-435), and colon adenocarcinoma (LOVO)
cell lines[99]. Cembrane-type diterpenoids and a known diterpe-
noid anadensin isolated from Tahitian liverwort Chandonanthus
hirtellus had shown weak cytotoxicity against HL-60.
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ether had indicated weak cytotoxicity against KB cell lines[63].
Examples of diterpenoids from other liverworts include Jun-
germannia atrobrunnea[100], Jungermannia exsertifolia ssp.
cordifolia[101], Jungermannia rotundata[102], Jungermannia hattoria
na[103], Jungermannia infusca[104–106], Jungermannia subulata (cell
suspension culture)[107], Jackiella javanica[108,109], Pellia
endiviifolia[110], P. perrottetiana[111], Porella densifolia[112], Porella
chilensis[113], Odontoschisma denudatum[114], Barbilopho
zia hatcheri[115], Frullania inouei[116], Frullania hamachiloba[117],
Pallavicinia subciliata[118], Scapania undulata[119], Jamesoniella
colorata[120], Jamesoniella kirkii[121], Trichocolea mollissima[122],
etc. Anticarcinogenic potential of widely distributed diterpenoids
from bryophyte genera could lead to its possible use as a therapy
against several human cancers.
2.1.4. Triterpenoids
Antitumor effect with apoptosis-inducing activity of penta-
cyclic triterpenoids and their saponins has been reported and
their structure-activity relationships (SARs) were discussed[123].
Plant-derived triterpenoids had shown promising activity on
various cancer cell lines[124]. Cytotoxicity of different secondary
metabolites isolated from the liverwort Ptilidium pulcherrimum
have been reported against the PC3, MDA-MB-231, and Hela
cells lines of which ursane triterpenoids had shown moderate
cytotoxicity against PC3 cells[125]. Other liverwort genera
reported for triterpenes are Fossombronia alaskana and
Fossombronia pusilla[126], Conocephalum japonicum[127],
Nardia scalaris[128], Blepharidophyllum densifolium[129], etc.
2.1.5. Bibenzyls and bisbenzyls
2.1.5.1. Riccardin
Cytotoxicity against the KB cells was shown by bis(bibenzyl)
riccardin from Riccardia multiﬁda (R. multiﬁda)[50]. Riccardin A
and riccardin B reported from R. multiﬁda were found to possess
cytotoxic activity[130]. Total syntheses of riccardin B from
liverworts have been reported[131]. Riccardin D, isolated from a
Chinese liverwort was found to possess pronounced
antiproliferative effect on human leukemia cell lines HL-60,
K562 and MDR K562/A02 cells. No induction of apoptosis in
topoisomerase-II-deﬁcient HL-60/MX2 cells indicates the mode
of action of riccardin D is DNA topoisomerase-II dependent[132].
2.1.5.2. Marchantin
Total syntheses of cytotoxic bis(bibenzyl) marchantin A from
liverworts were reported[131]. Cyto-chromes P-450 have been
found to catalyze the formation reaction of marchantins A and C
inM. polymorpha[133,134]. Marchantin A from M. polymorpha and
M. tosana had shown cytotoxicity against the KB cells[50].
Marchantin C from the New Zealand liverwort Schistochila
glaucescens was reported to be cytotoxic against P388
leukemia cells[61]. Marchantin C was found to promote
apoptosis in human glioma A172 cells. Bax-Bcl-2 regulation
could have been the factor of its pro-apoptotic nature[135].
Marchantin C from liverwort exhibited anti-tumor activity
in vivo and in vitro by arresting cell cycle at G(2)/M phase in
A172 and Hela cells and decreased microtubule quantity.
Marchantin C-treated human cervical carcinoma xenografts
showed increased cyclin B1, Bax, caspase-3 activity[136].
Antimicrotubule activities of marchantin A and C from the
liverwort Reboulia hemisphaerica were examined on humantumor cell line Hela (cervical carcinoma) and the compounds
were found to possess strong microtubule depolymerization
activities. Liquid chromatography with diode array detection/
mass spectroscopy (LC-DAD/MS/MS) techniques have been
utilized to detect the macrocyclic bisbibenzyls[137]. Marchantin
C was found to inhibit the migration in T98G and U87 glioma
cells. Matrix metallopeptidase 2, the key factor behind cancer
cell migration was found to be reduced in the treated cells.
Thus the compound could be used to prevent recurrent
tumors[138]. Marchantin C was found to act as a potent reversal
agent against vincristine-resistant KB/VCR cells by retarding
P-gp activity[139]. Marchantin A found in the liverwort
Marchantia emarginata subsp. tosana induced cell growth
inhibition leading to apoptosis in human MCF-7 breast cancer
cells. The compound increased the expression of p21 and p27
genes while genes like cyclin B1 and D1 were expressed in a
reduced manner[140].
2.1.5.3. Neomarchantins
The bisbibenzyls, neomarchantins A and B isolated from the
New Zealand liverwort Schistochila glaucescens were reported
to be cytotoxic against P388 leukemia cells[61].
2.1.5.4. Plagiochin
Another macrocyclic bisbibenzyl plagiochin E, isolated from
M. polymorpha had shown reversal effect on multidrug resis-
tance in adriamycin-resistant K562/A02 cells[141]. In addition,
plagiochin E was reported to induce apoptosis in Candida
albicans[142].
2.1.5.5. Isoplagiochin
Antimitotic macrocyclic bis(bibenzyls), isoplagiochins A and
B from the liverwort Plagiochila fruticosa had shown inhibitory
effect on tubulin polymerization[143].
2.1.5.6. Perrottetin
Cytotoxicity against the KB cells was shown by perrottetin E
from Radula perrottetii[50].
2.1.5.7. Dihydroptychantol A (DHA)
Reversal effect of DHA, another macrocyclic bisbibenzyl
from the liverwort Asterella angusta on multidrug resistance was
demonstrated[144]. Chemoresistant cancer cells like adriamycin-
resistant K562/A02 and vincristine-resistant KB/VCR lines
had exhibited reverting activity when exposed to DHA. This
could be a signiﬁcant aspect of multidrug resistance cancer cells
chemotherapy[145]. Chemically synthesized DHA was found to
induce autophagy, apoptotic cell death and cell cycle arrest at
G2/M-phase in human osteosarcoma U2OS cells. Expression
of nuclear p53 was found to increase while the cytoplasmic
p53 expression was decreased in the treated cells[146].
2.1.5.8. Lunularin
Lunularin from Dumortiera hirsuta showed moderate cyto-
toxicity against human HepG2 cells[45].
2.1.5.9. Other bis(bibenzyls)
Cyclic bisbibenzyls, riccardin C, pakyonol, marchantin M
and plagiochin E isolated from Asterella angusta, Plagiochasma
intermedium and M. polymorpha respectively were found to be
effective against chemoresistant prostate cancer PC3 cells. The
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Bcl-2, increase in expression of proapoptotic Bax and showed
PARP cleavage and caspase-3 activity. The changes were
detected by MTT [3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide] assay and Western blotting[147].
Cytotoxicity tests of methoxylated bibenzyls from the
liverwort Frullania inouei showed cytotoxic activity against
human tumor KB, KB/VCR, K562 or K562/A02 cells reversal
effect in vincristine-resistant KB/VCR and adriamycin-resistant
K562/A02 cells[116]. Cytotoxic bibenzyls from Indonesian and
Tahitian Frullania sp. and Japanese P. perrottetiana were
found effective against human promyelocytic leukemia (HL-
60) and human pharyngeal squamous carcinoma (KB) cell
lines determined by the water soluble tetrazolium-8 colori-
metric assay[64]. Blasia pusilla was found to possess
bis(bibenzyl) dimers, pusilatins showing moderate cytotoxicity
against KB cell line[148]. Cyclic bis(bibenzyls) isomarchantin C
and isoriccardin C from the Indian liverworts M. polymorpha
and Marchantia palmata have been reported[149].
Bis(bibenzyls) in bryophytes were studied using electron
ionization time-of-ﬂight and electrospray ionization triple-
quadrupole mass spectrometry[150]. Bryophyte crude extracts
were rapidly screened for bisbibenzyls using liquid
chromatography/tandem mass spectrometry[151]. Bibenzyls and/
or their derivatives were also recorded from liverworts such as
Plagiochila sp.[152,153], Plagiochila fruticosa[154,155], Marchantia
paleacea[156], Ptychantus striatus[157], Ricciocarpos natans[158],
Bazzania trilobata[159], Jubula japonica[73], R. multiﬁda subsp.
decrescens[160], Marsupidium epiphytum[161], Radula
marginata[162], Lepidozia incurvata[163], etc.
2.2. Hornworts
This is by far the most neglected class of bryophyte in terms of
phytochemical and pharmacological investigations. Being
phylogenetically important, the group is expected to possess some
unique metabolites with possible therapeutic value. Presence of
structurally different xyloglucans is noted in the cell wall of
hornworts which is similar to vascular plants and differs from
liverworts and mosses[164]. A sesquiterpene ether, veticadinoxide
from Anthoceros caucasicus was reported[165]. Phytochemical
analyses were performed in some other hornwort members such
as Anthoceros agrestis[166–169], Anthoceros caucasicus[170],
Megaceros ﬂagellaris[171], etc. Authors did not ﬁnd any report in
relation to cytotoxic compounds from the members of this group.
2.3. Mosses
Mono- and sesquiterpenoids are very rare in mosses, but di-
and triterpenoids have been reported from certain moss genera[26].
Extracts of Polytrichum juniperinum had shown activity against
sarcoma 37 in mice[172]. Variation in cytotoxicity and antitumor
activity among samples of a moss, Claopodium crispifolium
was noted. Enhancement of antitumor activity of the moss
could have been resulted due to interaction with the
cyanobacterium Nostoc cf. microscopicum or due to the
cyanobacterium itself[173]. Antitumor maytansinoids and the
members of the ansamycin group isolated from mosses are
ansamitocin P-3, 15-methoxyansamitocin P-3, maytanbutine
and trewiasine from different mosses such as Claopodium
crispifolium, Anomodon attenuates, Isothecium subdiversiformeand Thamnobrium sandei[173–175]. Ansamitocin P-3, with a very
low yield from Claopodium crispifolium and Anomodon
attenuatus exhibited signiﬁcant cytotoxicity against human
solid tumor cell lines A-549, HT-29 [175]. However, there are
debates of actual occurrence of maytansinoids in mosses[176].
Oncostatic as well as therapeutic nature of the peat preparation
in some types of human cancer were reported[177]. Cytotoxic
effect of fulvic acid (FA) extracted and puriﬁed from Canadian
Sphagnum peat on RBL-2H3 cells was analyzed by MTT
assay[178]. In another investigation, novel cytotoxic agents from
Polytrichum pallidisetum, ohioensins and pallidisetins have
been recorded. In this study, 1-O-methylohioensin B, 1-O-
methyldihydroohioensin B and 1,14-di-O-methyldihy-
droohioensin B, and two novel cinnamoyl bibenzyls, pallidisetin
A and pallidisetin B had shown cytotoxicity against the human
tumor cell lines RPMI-7951 melanoma and U-251 glioblastoma
multiforme[179], Ohioensins, a kind of benzonaphthoxanthenones
from Polytrichum ohioense was reported earlier[180].
Communins A and B and a new benzonaphthoxanthenone,
ohioensin H isolated from the moss Polytrichum commune
were tested against cancer cell lines[181], sanionins A and B
from the Antarctic moss Sanionia georgico-uncinata collected
from Livingston Island had shown weak cytotoxicity[33].
Photoprotective effects of extracts of Antarctic moss
Polytrichum juniperinum against UV induced DNA damage
was noted in hamster lung ﬁbroblasts (V79 cells)[182].
Triterpenes have been reported from other moss genera such as
Thuidium tamariscifolium[183], Floribundaria aurea subsp.
nipponica[184], etc. However their cytotoxic efﬁcacy is not yet
being tested.
2.4. Others
In a study, several species of bryophytes have been screened
for antitumor agents of which 43 species were found to be active
and 75 species were toxic to mice. The most activity was noted in
the families such as Brachytheciaceae, Grimmiaceae, Dicrana-
ceae, Mniaceae, Neckeraceae, Hypnaceae, Polytrichaceae and
Thuidiaceae[36]. Methyl ethyl ketone extract of Porella cordeana
produced drimenin and aristolone which were found to exhibit
moderate toxicity towards DNA-repair-deﬁcient mutants of
Saccharomyces cerevisiae[185]. Petroleum ether, ethyl acetate and
n-butanol leaf extracts of the folk medicinal hepatic Marchantia
convoluta showed cytotoxic effects to non-small cell lung carci-
noma (H1299) and liver carcinoma (HepG2) determined by 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
assay[186]. In vitro cytotoxic activity of M. convoluta ethyl acetate
extract on human liver and lung cancer cell lines (H1299 and
HepG2) were reported, where petroleum ether and n-butanol
extracts showed no activity[187]. Bryophytes extracts which
inhibit growth and induce abnormal phenotypes in human HeLa
cancer cells with signiﬁcant effects on interphasic and mitotic
cells, have been screened pharmacologically[188]. Luteolin,
another biologically active compound, reported from various
bryophytes and higher groups of plants is reported to induce
apoptosis, prevent carcinogenesis and reduce tumor growth
in vivo. This suggests that the ﬂavonoid has cancer
chemopreventive and chemotherapeutic potential[189]. Crude
extracts of the Tahitian Mastigophora diclados and Frullania
sp. and the Indonesian Frullania sp. exhibited cytotoxic activity
against HL-60 and KB cell lines[190]. A few aromatic
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been evaluated for cytotoxicity against the human KB cell line[191].
3. Discussion
Cancer is one of the most common diseases taking millions
of life per year. Apart from conventional treatments such as
surgery, radiation and chemotherapy against different types of
tumors and cancers, search for alternative and complementary
medicine to combat the disease is going on. Discovery of anti-
cancer agents from natural sources has been a major ﬁeld of
investigation in the last few decades. Various types of chemi-
cally diverged compounds have been isolated from natural
sources and screened for cytotoxicity against cancer cell lines.
Drug resistant cancer cell lines had shown reversal effect when
exposed to certain natural and novel compounds. However the
exact molecular mechanism remains unknown in many of the
inhibitory reactions.
Bryophytes are phylogenetically placed between algae and
pteridophytes and considered among the ﬁrst land plants. A
number of bryophytes have been used in traditional system of
medicine to treat various ailments. Several bioactive and
medicinally important compounds have been isolated and
pharmacologically tested for their efﬁcacy. Some of the active
biomolecules such as terpenoids and phenolic bibenzyls have
been studied for cytotoxicity against different human cancer cell
lines. Many of the experiments have produced positive results
indicating anticancerous efﬁcacy of the compounds. Several
genetic and biochemical pathways were found to be activated in
order to induce apoptosis and necrosis by the biomolecules. It
was also noted that, a very small fraction of bryophytes has been
tested for their pharmacological efﬁcacy. Although the exact
mode of action of some of these bioactive compounds remains
unknown, bryophytes could serve as an attractive candidate for
therapeutic properties. Isolation, characterization, structural
elucidation, pharmacological evaluation, determination of mode
of action and clinical trial of these active principles could open
an exciting aspect of future drug development programs. In
addition, Structure-activity relationship of some of the cytotoxic
compounds has been worked out. But, a number of such com-
pounds are yet to be investigated. With the advent of modern
tools such as high performance liquid chromatography, high
performance thin layer chromatography, liquid chromatography,
mass spectroscopy, liquid chromatography with diode array
detection, X-ray crystallography etc. it has become easier to
elucidate the relationship between the structure and activity of
several biomolecules. However, active constituents of plants
may vary depending on the season, altitude, type of tissue har-
vested and extraction condition. Therefore, it is important to
consider all these factors while analyzing pharmacological efﬁ-
cacy of crude extracts. Most of these antiproliferative com-
pounds belong to the liverwort genera while the mosses possess
a few of them. The authors have found no report on cytotoxic
potential of the hornworts. Keeping in mind its evolutionary
signiﬁcance, phytochemical and pharmacological studies of this
group may lead to the discovery of certain novel metabolites
having unique therapeutic potential.
Bryophytes, considered as the earliest land plants, synthesize
a number of secondary metabolites to combat against different
kinds of stress. Due to the presence of these phytochemicals they
are able to cope up with infection, predation, radiation and
temperature and salinity ﬂuctuation. The diverse and novelnature of secondary constituents could be exploited by phar-
macological investigation, phytochemical evaluation and clinical
trials. Development of drug resistance in proliferative cells as
well as in microbes can be controlled by using such novel nat-
ural products. The possible use of bryophytes as medicine may
lead to cure of different ailments which have been difﬁcult to
treat by conventional medicine.
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